| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8531044 | International Immunopharmacology | 2018 | 8 Pages |
Abstract
Our study suggests that the increase in proportion of Th17 cells might contribute to the pathogenesis of RRMS. The results of the current work indicated that nanocurcumin is able to restore the dysregulated of Th17 cells in MS patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sanam Dolati, Majid Ahmadi, Reza Rikhtegar, Zohreh Babaloo, Hormoz Ayromlou, Leili Aghebati-Maleki, Mohammad Nouri, Mehdi Yousefi,